- Home
- WYY vs ESLA Comparison
WYY vs ESLA Comparison
Compare WYY & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- ESLA
- Stock Information
- Founded
- WYY 1991
- ESLA 2021
- Country
- WYY United States
- ESLA United States
- Employees
- WYY N/A
- ESLA N/A
- Industry
- WYY EDP Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WYY Technology
- ESLA Health Care
- Exchange
- WYY Nasdaq
- ESLA Nasdaq
- Market Cap
- WYY 48.9M
- ESLA 48.9M
- IPO Year
- WYY 1998
- ESLA N/A
- Fundamental
- Price
- WYY $5.50
- ESLA $1.26
- Analyst Decision
- WYY Strong Buy
- ESLA Strong Buy
- Analyst Count
- WYY 3
- ESLA 1
- Target Price
- WYY $8.00
- ESLA $16.00
- AVG Volume (30 Days)
- WYY 53.7K
- ESLA 115.6K
- Earning Date
- WYY 11-12-2025
- ESLA 11-20-2025
- Dividend Yield
- WYY N/A
- ESLA N/A
- EPS Growth
- WYY N/A
- ESLA N/A
- EPS
- WYY N/A
- ESLA N/A
- Revenue
- WYY $144,421,640.00
- ESLA N/A
- Revenue This Year
- WYY $9.19
- ESLA N/A
- Revenue Next Year
- WYY $13.16
- ESLA N/A
- P/E Ratio
- WYY N/A
- ESLA N/A
- Revenue Growth
- WYY 16.25
- ESLA N/A
- 52 Week Low
- WYY $2.19
- ESLA $0.63
- 52 Week High
- WYY $6.25
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- WYY 59.73
- ESLA 54.90
- Support Level
- WYY $5.00
- ESLA $1.12
- Resistance Level
- WYY $5.39
- ESLA $1.48
- Average True Range (ATR)
- WYY 0.31
- ESLA 0.13
- MACD
- WYY -0.05
- ESLA 0.01
- Stochastic Oscillator
- WYY 63.86
- ESLA 31.82
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.